USA - NYSE:CXT - US2244411052 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to CXT. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-09-23 | DA Davidson | Maintains | Buy -> Buy |
| 2025-09-15 | DA Davidson | Maintains | Buy -> Buy |
| 2025-08-18 | DA Davidson | Maintains | Buy -> Buy |
| 2025-05-13 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-09 | DA Davidson | Maintains | Buy -> Buy |
| 2024-11-08 | Baird | Maintains | Outperform -> Outperform |
| 2024-10-17 | Baird | Initiate | Outperform |
| 2024-10-07 | Northland Capital Markets | Maintains | Outperform -> Outperform |
| 2024-09-30 | DA Davidson | Maintains | Buy -> Buy |
| 2024-04-08 | Northland Capital Markets | Initiate | Outperform |
| 2024-03-18 | DA Davidson | Maintains | Buy -> Buy |
| 2024-03-12 | DA Davidson | Maintains | Buy -> Buy |
| 2024-03-04 | DA Davidson | Reiterate | Buy -> Buy |
| 2024-01-18 | DA Davidson | Maintains | Buy -> Buy |
| 2023-08-29 | UBS | Initiate | Neutral |
| 2023-06-13 | Oppenheimer | Initiate | Outperform |
| 2023-05-12 | DA Davidson | Maintains | Buy -> Buy |
| 2023-04-04 | DA Davidson | Initiate | Buy |
11 analysts have analysed CXT and the average price target is 95.15 USD. This implies a price increase of 75.57% is expected in the next year compared to the current price of 54.195.
The consensus rating for CRANE NXT CO (CXT) is 81.8182 / 100 . This indicates that analysts generally have a positive outlook on the stock.